Serina Therapeutics (SER) Other Non Operating Income (2018 - 2026)
Serina Therapeutics (SER) posted Other Non Operating Income of -$100000.0 for Q4 2025, down 385.71% sequentially from $35000.0 in Q3 2025, and down 332.56% YoY from $43000.0 in Q4 2024.
Serina Therapeutics (SER) Other Non Operating Income (2018 - 2026) Analysis & Trends
Serina Therapeutics has reported Other Non Operating Income for 8 years, with the latest figure at -$100000.0 in Q4 2025.
- Quarterly Other Non Operating Income fell 332.56% year-over-year to -$100000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $50000.0 (down 78.07% YoY) and the FY2025 annual result came in at $51000.0, down 77.63% from the prior year.
- Other Non Operating Income fell to -$100000.0 in Q4 2025 per SER's latest filing, from $35000.0 in the prior quarter.
- Over five years, Other Non Operating Income peaked at $106000.0 in Q1 2021 and troughed at -$100000.0 in Q4 2025.
- A 5-year average of $31894.7 and a median of $35000.0 in 2025 frame the typical range for Other Non Operating Income.
- The sharpest annual moves came in 2023 and 2025: Other Non Operating Income soared 5150.0% in 2023, then slumped 332.56% in 2025.
- Over 5 years, Other Non Operating Income stood at $4000.0 in 2021, then changed by 0.0% to $4000.0 in 2022, then soared by 2125.0% to $89000.0 in 2023, then plunged by 51.69% to $43000.0 in 2024, then plunged by 332.56% to -$100000.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered -$100000.0, $35000.0, and $68000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 43,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 56,000.00 |
| Mar 31, 2024 | 87,000.00 |
| Dec 31, 2023 | 89,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 4,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Sep 30, 2021 | 4,000.00 |
| Jun 30, 2021 | 4,000.00 |
| Mar 31, 2021 | 106,000.00 |